AbCellera Biologics Inc.
Monoclonal antibody drug candidates for therapeutic use
- Sector
- Biotech
- Headquarters
- VANCOUVER, A1
- Founded
- 2012
- Latest Form D
- $74.5M, May 2020
- Total capital
- $83.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $83.1M
- 4 Form D · last May 2020
- 77 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 18 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$74.5M
- Private capital raisedForm D · SEC · 3rd filing$7.7M
- Private capital raisedForm D · SEC · 2nd filing$50K
- Private capital raisedForm D · SEC · 1st filing$818K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Andrew BoothDirectorNamed in SEC Form D filings
- Carl HansenExecutive Officer, DirectorNamed in SEC Form D filings
- Doug JanzenExecutive Officer, DirectorNamed in SEC Form D filings
- John HamerDirectorNamed in SEC Form D filings
- Michael HaydenDirectorNamed in SEC Form D filings
- Stimart TrynExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Veronique LecaultDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 18- PendingAntibody Competition Model Using Hidden Variable AffinitiesUSPTOApplication 17860760
- PendingTrangenic Rodents For Cell Line Identification And EnrichmentUSPTOApplication 18695100
- PendingCD3 T-Cell Engagers and Methods of UseUSPTOApplication 18186429
Show all 18 patent records
- Antibody Competition Model Using Hidden Variable AffinitiesNov 27, 2025 · Application 17860760Pending
- Trangenic Rodents For Cell Line Identification And EnrichmentOct 16, 2025 · Application 18695100Pending
- CD3 T-Cell Engagers and Methods of UseSep 21, 2023 · Application 18186429Pending
- Anti-NK3R Antibodies and Methods of UseApplication 63594517Pending
- Anti-OX40L Antibodies and Methods of UseApplication 63592351Pending
- CD3 T-cell Engagers And Methods Of UseApplication PCTUS2023064693Pending
- Transgenic Rodents For Cell Line Identification And EnrichmentApplication PCTUS2022077363Pending
- Antibody Competition Model Using Hidden Variable AffinitiesApplication PCTUS2022036517Pending
- CD3 T-Cell Engagers and Methods of UseApplication 63321745Pending
- Transgenic Rodents For Cell Line Identification And EnrichmentApplication 63261987Pending
- ANTI-SARS-COV-2 AntibodiesApplication PCTUS2021045466Pending
- Antibody Competition Model Using Hidden Variable AffinitiesApplication 63219578Pending
- ANTI-SARS-COV-2 AntibodiesApplication 63064163Pending
- Anti-NK3R Antibodies and Methods of UseApplication 19583584Pending
- ANTI-NK3R Antibodies And Methods Of UseApplication PCTUS2024053846Pending
- Anti-OX40L Antibodies and Methods of UseApplication 19581193Pending
- ANTI-OX40L Antibodies And Methods Of UseApplication PCTUS2024052505Pending
- Anti-OX40L Antibodies and Methods of UseApplication 63642002Pending
Related companies, and why
- Ascendis Pharma A/SSimilar federal contract value in Biotech · null in contracts
- PhaseBio Pharmaceuticals IncSimilar federal contract value in Biotech · null in contracts
- STREAM BIOMEDICAL INCSimilar federal contract value in Biotech · null in contracts
- TWOXAR, INC.Similar federal contract value in Biotech · null in contracts
- PRIMROSE BIO, INC.Similar federal contract value in Biotech · null in contracts
- XDEMICS CORPORATIONSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .